IL33 and type III hypersensitivity disease: Rather, consistent with published results demonstrating the key role of FcγRIII in synovial MC activation [33], [35], our data suggest that constitutive signals mediated via IL-33 promote immune complex responsiveness of synovial MCs, defining therefore a new model for a permissive role of IL-33 in MC-dependent immune complex disease (Figure 5).